These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 8255457)

  • 21. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of CMT1A and CMT2: similarities and differences.
    Bienfait HM; Verhamme C; van Schaik IN; Koelman JH; de Visser BW; de Haan RJ; Baas F; van Engelen BG; de Visser M
    J Neurol; 2006 Dec; 253(12):1572-80. PubMed ID: 16941080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic linkage evidence for heterogeneity in Charcot-Marie-Tooth neuropathy (HMSN type I).
    Bird TD; Ott J; Giblett ER; Chance PF; Sumi SM; Kraft GH
    Ann Neurol; 1983 Dec; 14(6):679-84. PubMed ID: 6651251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation testing in Charcot-Marie-Tooth neuropathy.
    Nicholson GA
    Ann N Y Acad Sci; 1999 Sep; 883():383-8. PubMed ID: 10586262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and electrophysiological studies of a family with probable X-linked dominant Charcot-Marie-Tooth neuropathy and ptosis.
    Wu T; Wang HL; Chu CC; Yu JM; Chen JY; Huang CC
    Chang Gung Med J; 2004 Jul; 27(7):489-500. PubMed ID: 15508871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.
    Claeys KG; Züchner S; Kennerson M; Berciano J; Garcia A; Verhoeven K; Storey E; Merory JR; Bienfait HM; Lammens M; Nelis E; Baets J; De Vriendt E; Berneman ZN; De Veuster I; Vance JM; Nicholson G; Timmerman V; De Jonghe P
    Brain; 2009 Jul; 132(Pt 7):1741-52. PubMed ID: 19502294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and molecular studies in a family with probable X-linked dominant Charcot-Marie-Tooth disease involving the central nervous system.
    Hisama FM; Lee HH; Vashlishan A; Tekumalla P; Russell DS; Auld E; Goldstein JM
    Arch Neurol; 2001 Nov; 58(11):1891-6. PubMed ID: 11709000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy.
    Killian JM; Tiwari PS; Jacobson S; Jackson RD; Lupski JR
    Muscle Nerve; 1996 Jan; 19(1):74-8. PubMed ID: 8538673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.
    Pareyson D; Scaioli V; Laurà M
    Neuromolecular Med; 2006; 8(1-2):3-22. PubMed ID: 16775364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy.
    Ionasescu VV; Trofatter J; Haines JL; Summers AM; Ionasescu R; Searby C
    Am J Hum Genet; 1991 Jun; 48(6):1075-83. PubMed ID: 1674639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited peripheral neuropathy.
    Keller MP; Chance PF
    Semin Neurol; 1999; 19(4):353-62. PubMed ID: 10716658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermediate conduction velocity in two cases of Charcot-Marie-Tooth disease type 1A.
    Tomaselli PJ; Blake J; Polke JM; do Nascimento OJM; Reilly MM; Marques Júnior W; Laurá M
    Eur J Neurol; 2024 May; 31(5):e16199. PubMed ID: 38409938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nerve ultrasound findings differentiate Charcot-Marie-Tooth disease (CMT) 1A from other demyelinating CMTs.
    Zanette G; Fabrizi GM; Taioli F; Lauriola MF; Badari A; Ferrarini M; Cavallaro T; Tamburin S
    Clin Neurophysiol; 2018 Nov; 129(11):2259-2267. PubMed ID: 30216910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected Intermediate Nerve Conduction Velocity Findings in Charcot-Marie-Tooth Syndromes Classified as Demyelinated or Axonal in a Pediatric Population.
    Baudou E; Cances C; Magdelaine C; Latour P; Louvier UW; Juntas-Morales R; Cintas P; Rivier F
    Neuropediatrics; 2022 Jun; 53(3):182-187. PubMed ID: 35297028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP.
    Schreiber S; Oldag A; Kornblum C; Kollewe K; Kropf S; Schoenfeld A; Feistner H; Jakubiczka S; Kunz WS; Scherlach C; Tempelmann C; Mawrin C; Dengler R; Schreiber F; Goertler M; Vielhaber S
    Muscle Nerve; 2013 Mar; 47(3):385-95. PubMed ID: 23381770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.
    Bird TD; Kraft GH; Lipe HP; Kenney KL; Sumi SM
    Ann Neurol; 1997 Apr; 41(4):463-9. PubMed ID: 9124803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-linked Charcot-Marie-Tooth disease: molecular analysis of interfamilial variability.
    Niewiadomski LA; Kelly TE
    Am J Med Genet; 1996 Dec; 66(2):175-8. PubMed ID: 8958325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease.
    Kessali M; Zemmouri R; Guilbot A; Maisonobe T; Brice A; LeGuern E; Grid D
    Neurology; 1997 Apr; 48(4):867-73. PubMed ID: 9109869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelization of motor nerve conduction velocities for Charcot-Marie-Tooth (Type-1) patients. CMT-France Network.
    Sturtz FG; Chauvin F; Ollagnon-Roman E; Bost M; Latour P; Bonnebouche C; Gonnaud PM; Bady B; Chazot G; Vandenberghe A
    Eur Neurol; 1996; 36(4):224-8. PubMed ID: 8814426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Review of X-linked Charcot-Marie-Tooth Disease.
    Wang Y; Yin F
    J Child Neurol; 2016 May; 31(6):761-72. PubMed ID: 26385972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.